A phase II study to determine the safety and efficacy of Tarceva (erlotinib hydrochloride) with concurrent whole brain radiation therapy in patients with brain metastases from non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2006
At a glance
- Drugs Erlotinib (Primary)
- Indications Cancer metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Jun 2006 New trial record.